Page 140 - Read Online

Santiago et al. J Transl Genet Genom 2021;5:380-95 https://dx.doi.org/10.20517/jtgg.2021.16 Page 392

7. Vrooman LM, Blonquist TM, Harris MH, et al. Refining risk classification in childhood B acute lymphoblastic leukemia: results of
DFCI ALL Consortium Protocol 05-001. Blood Adv 2018;2:1449-58. DOI PubMed PMC
8. Tasian SK, Hunger SP. Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine
therapeutics. Br J Haematol 2017;176:867-82. DOI PubMed PMC
9. Mullighan CG. How advanced are we in targeting novel subtypes of ALL? Best Pract Res Clin Haematol 2019;32:101095. DOI
PubMed PMC
10. Tran TH, Hunger SP. The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities. Semin
Cancer Biol 2020:S1044-579X(20)30218. DOI PubMed
11. Gu Z, Churchman ML, Roberts KG, et al. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. Nat Genet
2019;51:296-307. DOI PubMed PMC
12. Yeoh E, Ross ME, Shurtleff SA, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic
leukemia by gene expression profiling. Cancer Cell 2002;1:133-43. DOI PubMed
13. Kang H, Chen IM, Wilson CS, et al. Gene expression classifiers for relapse-free survival and minimal residual disease improve risk
classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia. Blood 2010;115:1394-405. DOI
PubMed PMC
14. Harvey RC, Mullighan CG, Wang X, et al. Identification of novel cluster groups in pediatric high-risk B-precursor acute
lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical
characteristics, and outcome. Blood 2010;116:4874-84. DOI PubMed PMC
15. Den Boer ML, van Slegtenhorst M, De Menezes RX, et al. A subtype of childhood acute lymphoblastic leukaemia with poor
treatment outcome: a genome-wide classification study. Lancet Oncol 2009;10:125-34. DOI PubMed PMC
16. Mullighan CG, Su X, Zhang J, et al; Children's Oncology Group. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.
N Engl J Med 2009;360:470-80. DOI PubMed PMC
17. Harvey RC, Mullighan CG, Chen IM, et al. Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of
IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia. Blood
2010;115:5312-21. DOI PubMed PMC
18. Loh ML, Zhang J, Harvey RC, et al. Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the
Children's Oncology Group TARGET Project. Blood 2013;121:485-8. DOI PubMed PMC
19. Roberts KG, Li Y, Payne-Turner D, et al. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med
2014;371:1005-15. DOI PubMed PMC
20. Tran TH, Loh ML. Ph-like acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program 2016;2016:561-6. DOI
PubMed PMC
21. Iacobucci I, Storlazzi CT, Cilloni D, et al. Identification and molecular characterization of recurrent genomic deletions on 7p12 in the
IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie
Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP). Blood 2009;114:2159-67. DOI PubMed
22. Vairy S, Tran TH. IKZF1 alterations in acute lymphoblastic leukemia: The good, the bad and the ugly. Blood Rev 2020;44:100677.
DOI PubMed
23. Tran TH, Harris MH, Nguyen JV, et al. Prognostic impact of kinase-activating fusions and IKZF1 deletions in pediatric high-risk B-
lineage acute lymphoblastic leukemia. Blood Adv 2018;2:529-33. DOI PubMed PMC
24. Chen IM, Harvey RC, Mullighan CG, et al. Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric
acute lymphoblastic leukemia: a Children's Oncology Group study. Blood 2012;119:3512-22. DOI PubMed PMC
25. Stanulla M, Dagdan E, Zaliova M, et al; TRANSCALL Consortium; International BFM Study Group. IKZF1 plus defines a new
minimal residual disease-dependent very-poor prognostic profile in pediatric B-cell precursor acute lymphoblastic leukemia. J Clin
Oncol 2018;36:1240-9. DOI PubMed
26. Zhang J, McCastlain K, Yoshihara H, et al; St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome
Project. Deregulation of DUX4 and ERG in acute lymphoblastic leukemia. Nat Genet 2016;48:1481-9. DOI PubMed PMC
27. Lilljebjörn H, Henningsson R, Hyrenius-Wittsten A, et al. Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in
paediatric B-cell precursor acute lymphoblastic leukaemia. Nat Commun 2016;7:11790. DOI PubMed PMC
28. Clappier E, Auclerc MF, Rapion J, et al. An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute
lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions. Leukemia 2014;28:70-7. DOI PubMed
29. Zaliova M, Zimmermannova O, Dörge P, et al. ERG deletion is associated with CD2 and attenuates the negative impact of IKZF1
deletion in childhood acute lymphoblastic leukemia. Leukemia 2014;28:182-5. DOI PubMed
30. Zaliova M, Kotrova M, Bresolin S, et al. ETV6/RUNX1-like acute lymphoblastic leukemia: A novel B-cell precursor leukemia
subtype associated with the CD27/CD44 immunophenotype. Genes Chromosomes Cancer 2017;56:608-16. DOI PubMed
31. Li JF, Dai YT, Lilljebjörn H, et al. Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an
international study of 1,223 cases. Proc Natl Acad Sci U S A 2018;115:E11711-20. DOI PubMed PMC
32. Liu YF, Wang BY, Zhang WN, et al. Genomic profiling of adult and pediatric B-cell acute lymphoblastic leukemia. EBioMedicine
2016;8:173-83. DOI PubMed PMC
33. Gu Z, Churchman M, Roberts K, et al. Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia. Nat
Commun 2016;7:13331. DOI PubMed PMC
34. Hirabayashi S, Ohki K, Nakabayashi K, et al; Tokyo Children’s Cancer Study Group (TCCSG). ZNF384-related fusion genes define
a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype. Haematologica